PODD - Insulet Corp Stock Price, Fair Value and News

$262.63+0.63 (+0.24%)

Delayed as of 22 Nov 2024, 12:57 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PODD Price Action

Last 7 days

0.5%

Last 30 days

10.9%

Last 90 days

41.8%

Trailing 12 Months

40.8%

PODD RSI Chart

PODD Valuation

Market Cap

18.4B

Price/Earnings (Trailing)

43.66

Price/Sales (Trailing)

9.26

EV/EBITDA

50.24

Price/Free Cashflow

80.89

PODD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PODD Fundamentals

PODD Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

25.7%

Rev. Growth (Qtr)

11.34%

PODD Earnings

Earnings (TTM)

420.9M

Earnings Growth (Yr)

49.33%

Earnings Growth (Qtr)

-58.91%

PODD Profitability

EBT Margin

14.96%

Return on Equity

37.65%

Return on Assets

13.91%

Free Cashflow Yield

1.24%

PODD Investor Care

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

5.87

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.8B	1.9B	2.0B	0
2023	1.4B	1.5B	1.6B	1.7B
2022	1.1B	1.2B	1.2B	1.3B
2021	958.7M	995.6M	1.0B	1.1B
2020	776.6M	825.8M	867.7M	904.4M
2019	599.8M	652.7M	693.7M	738.2M
2018	485.7M	500.1M	529.4M	563.8M
2017	387.5M	409.9M	436.8M	463.8M
2016	297.0M	323.7M	347.2M	367.0M
2015	224.1M	227.1M	238.5M	263.9M
2014	245.1M	242.6M	241.5M	231.3M
2013	221.0M	230.0M	236.4M	247.1M
2012	171.8M	190.6M	200.7M	211.4M
2011	104.4M	113.7M	132.8M	152.3M
2010	73.8M	81.5M	89.2M	97.0M
2009	0	0	0	66.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

CEO	Dr. James R. Hollingshead Ph.D.
WEBSITE	insulet.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	2600

Insulet Corp Frequently Asked Questions

What is the ticker symbol for Insulet Corp? What does PODD stand for in stocks?

PODD is the stock ticker symbol of Insulet Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Insulet Corp (PODD)?

As of Thu Nov 21 2024, market cap of Insulet Corp is 18.38 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PODD stock?

You can check PODD's fair value in chart for subscribers.

Is Insulet Corp a good stock to buy?

The fair value guage provides a quick view whether PODD is over valued or under valued. Whether Insulet Corp is cheap or expensive depends on the assumptions which impact Insulet Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PODD.

What is Insulet Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, PODD's PE ratio (Price to Earnings) is 43.66 and Price to Sales (PS) ratio is 9.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PODD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Insulet Corp's stock?

In the past 10 years, Insulet Corp has provided 0.19 (multiply by 100 for percentage) rate of return.